Publications by authors named "Julia Arebro"

Acute onset of vertigo and hearing loss is rare in leukemic disorders. MRI can diagnose intracochlear hemorrhage as the underlying cause. The hearing can improve but if severe hearing loss preserves, cochlear implantation can be considered.

View Article and Find Full Text PDF

Oral squamous cell carcinoma (OSCC) remains an understudied and significant global cancer killer and dismal survival rates have not changed in decades. A better understanding of the molecular basis of OSCC progression and metastasis is needed to develop new approaches for treating this disease. The supportive network surrounding cancer tumor cells known as the tumor microenvironment (TME) has gained increasing interest lately since it performs essential protumorigenic functions.

View Article and Find Full Text PDF
Article Synopsis
  • - Oral squamous cell carcinoma (OSCC) is a prevalent head and neck cancer with a low 5-year survival rate, highlighting the urgent need for improved treatment strategies and a deeper understanding of tumor development mechanisms.
  • - The tumor microenvironment (TME), especially cancer-associated fibroblasts (CAFs), plays a vital role in tumor progression, and recent studies are investigating how extracellular vesicles (EVs) from OSCC cells contribute to CAF activation.
  • - Research findings indicate that OSCC-derived EVs can activate oral fibroblasts into unique CAFs with distinct inflammatory profiles that differ from those activated by traditional pathways like TGFβ, suggesting alternative mechanisms and potential new therapeutic targets.
View Article and Find Full Text PDF

Postsurgical pyoderma gangrenosum (PSPG) develops in the skin after surgery without known cause. Immunosuppression constitutes first-line therapy and increases the likelihood of successful surgery when needed. PSPG should be considered when a flap necrosis occurs.

View Article and Find Full Text PDF

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a widespread disease causing obstruction of the nasal cavity. Its cause remains unclear. The transforming growth-factor beta (TGF-β) superfamily and their receptors, termed Activin receptor-like kinases (ALKs), have recently been suggested to play a role in local airway inflammation, but have so far not been evaluated in human nasal epithelial cells (HNECs) from CRSwNP patients.

View Article and Find Full Text PDF

A re-examination of former concepts is required to meet today's medical challenges in allergic rhinitis. Previously, neutrophils have been treated as a relatively homogenous cell population found in the nose both when the patient is suffering at the height of the allergic season as well as when the patient report no symptoms. However, new data indicates that neutrophils can be divided into different subsets with diverse roles in inflammation.

View Article and Find Full Text PDF

Background: Current phenotyping of chronic rhinosinusitis (CRS) into chronic rhinosinusitis with nasal polyps (CRSwNP) and chronic rhinosinusitis without nasal polyps (CRSsNP) might not adequately reflect the pathophysiologic diversity within patients with CRS.

Objective: We sought to identify inflammatory endotypes of CRS. Therefore we aimed to cluster patients with CRS based solely on immune markers in a phenotype-free approach.

View Article and Find Full Text PDF

Background: The origin of nasal polyps in chronic rhinosinusitis is unknown, but the role of viral infections in polyp growth is clinically well established. Toll-like receptors (TLRs) have recently emerged as key players in our local airway defense against microbes. Among these, TLR9 has gained special interest in viral diseases.

View Article and Find Full Text PDF
Article Synopsis
  • A new endoscopic surgical technique was found to be safe and effective for treating subglottic stenosis caused by Wegener's granulomatosis, with an overall success rate of 85%.
  • The study involved 13 patients who underwent a total of 37 procedures, and results showed a significant reduction in symptoms after treatment.
  • Patients were monitored over an average follow-up period of 3.5 years, and only one patient experienced a relapse post-treatment, with no recorded deaths during the procedures.
View Article and Find Full Text PDF